文献速递肾小球疾病慢性肾脏病急性肾损伤

成人肾病综合征患者与肾脏生存的国家注册研究

A National Registry Study of Patient and Renal Survival in Adult Nephrotic Syndrome.
PubMed 文献 · Kidney Int Rep · 2020-11-04

该研究基于苏格兰国家注册数据,纳入2014-2017年因肾病综合征接受肾活检的522例成人,分析死亡与终末期肾病(ESKD)结局。中位随访866天,21%死亡,15%进展至ESKD;原发性与继发性肾病综合征患者死亡率均高于年龄性别匹配的普通人群,且心血管原因在原发组死亡中占比更高。早期蛋白尿缓解和无早期急性肾损伤与较低死亡和ESKD风险相关。

要点

  • 成人肾病综合征死亡和ESKD风险高,继发性者3年ESKD发生率35.1%。
  • 原发与继发性肾病综合征患者死亡率均显著高于匹配普通人群。
  • 早期蛋白尿缓解及无早期AKI与更低死亡和ESKD风险相关。

核心结论

  • 成人肾病综合征患者死亡率和ESKD发生率均高,原发性者心血管原因导致超额死亡。
  • 早期蛋白尿缓解和无早期AKI与较低的死亡及ESKD风险相关。

研究设计与样本

  • 基于国家注册的队列研究,纳入2014-2017年苏格兰所有因肾病综合征行肾活检的522例成人。
  • 链接苏格兰肾脏注册与死亡证明数据,进行生存分析和Cox比例风险分析,并考虑死亡与ESKD的竞争风险。
  • 将死亡率与年龄和性别匹配的普通人群进行比较。

主要发现

  • 原发性肾病综合征患者3年死亡率:<60岁为2.1%(95%CI 0.0%-4.6%),≥60岁为24.9%(18.4%-30.8%)。
  • 继发性肾病综合征患者3年死亡率:<60岁为17.1%(5.6%-27.2%),≥60岁为49.4%(36.6%-59.7%)。
  • 原发性肾病综合征3年ESKD发生率为8.4%(95%CI 4.9%-11.7%),继发性为35.1%(24.3%-44.5%)。
  • 原发性肾病综合征死亡中心血管原因占28%,普通人群为18%。

临床怎么用

  • 对成人肾病综合征患者应重视心血管风险评估与管理,尤其原发性者。
  • 监测并促进早期蛋白尿缓解,预防早期AKI,可能降低死亡和ESKD风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: We aimed to determine the mortality rate, cause of death, and rate of end-stage kidney disease (ESKD) in adults with nephrotic syndrome (NS). METHODS: We conducted a national registry-based study, including all 522 adults who had a kidney biopsy for NS in Scotland in 2014-2017. We linked the Scottish Renal Registry to death certificate data. We performed survival and Cox proportional hazards analyses, accounting for competing risks of death and ESKD. We compared mortality rates with those in the age- and sex-matched general population. RESULTS: A total of 372 patients had primary NS; 150 had secondary NS. Over a median follow-up of 866 days, 110 patients (21%) died. In patients with primary NS, observed versus population 3-year mortality was 2.1% (95% CI 0.0%-4.6%) versus 0.9% (0.8%-1.0%) in patients aged <60 years and 24.9% (18.4%-30.8%) versus 9.4% (8.3%-10.5%) in those aged ≥60 years. In secondary NS, this discrepancy was 17.1% (5.6%-27.2%) versus 1.1% (0.9%-1.2%) in <60-year-olds and 49.4% (36.6%-59.7%) versus 8.1% (6.6%-9.6%) in ≥60-year-olds. In primary NS, cardiovascular causes accounted for 28% of deaths, compared with 18% in the general population. Eighty patients (15%) progressed to ESKD. Incidence of ESKD by 3 years was 8.4% (95% CI 4.9%-11.7%) in primary and 35.1% (24.3%-44.5%) in secondary NS. Early remission of proteinuria and the absence of early acute kidney injury (AKI) were associated with lower rates of death and ESKD. CONCLUSIONS: Adults with NS have high rates of death and ESKD. Cardiovascular causes account for excess mortality in primary NS.

来源:Kidney Int Rep,查看原文。版权归原作者所有。

引用

  1. Kolb A, Gallacher PJ, Campbell J, et al. A National Registry Study of Patient and Renal Survival in Adult Nephrotic Syndrome. Kidney Int Rep. 2020. PMID: 33615070. doi:10.1016/j.ekir.2020.10.033

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。